Search company, investor...

Founded Year



Debt | Alive

Total Raised


Last Raised

$34M | 9 yrs ago

About Green Biologics

Green Biologics is an industrial biotechnology company focused on the production of renewable n-butanol and other C4 chemicals from various renewable feedstocks, including sugar (cane, molasses, beets), starch (corn) and cellulosic biomass (corn residues, sugar cane bagasse, forest materials and grasses). The company works with feedstock partners to deliver capital efficient production models, and works with downstream partners to deliver high quality, competitively priced products. Green Biologics' focus is on the global renewable chemicals and biofuels markets.

Headquarters Location

80F Park Drive, Milton Park Abingdon

Oxon, OX14 4RY,

United Kingdom

+44 1235 435710



Expert Collections containing Green Biologics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Green Biologics is included in 3 Expert Collections, including Synthetic Biology.


Synthetic Biology

305 items

Companies involved in design and development of new biological parts, devices, and systems; as well as the re-design of existing biological systems.


Renewable Energy

3,320 items

Companies in the Renewable Energy space, including solar, wind, hydro, geothermal, and nuclear energy providers, as well as related software developers.


Advanced Materials

1,364 items

Companies in the advanced materials space, including polymers, biomaterials, semiconductor materials, and more

Green Biologics Patents

Green Biologics has filed 11 patents.

patents chart

Application Date

Grant Date


Related Topics




Molecular biology, Genetics, Biotechnology, Genetic engineering, Molecular genetics


Application Date


Grant Date



Related Topics

Molecular biology, Genetics, Biotechnology, Genetic engineering, Molecular genetics



Latest Green Biologics News

Global Cellulosic Advanced Biofuels Market Size & Trends

Oct 30, 2023

The key players operating in the market are POET, LLC, Abengoa Bioenergy, DuPont, GranBio, INEOS Bio, DSM, Beta Renewables, LanzaTech, Fiberight, Qetros, CoolPlanet, Mascoma Corporation, Cobalt Technologies, Amryis Biotechnologies, Gevo, Inc., and Green Biologics, among others. October 30, 2023 13:31 ET Mumbai, INDIA Brooklyn, New York, Oct. 30, 2023 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the global cellulosic advanced biofuels market is expected to grow at a CAGR of 8.5% from 2023 to 2028. Global cellulosic advanced biofuels market growth is driven by the increasing demand for renewable fuel sources, sustainability, and technological advancements. Key Market Trends The growth of the global cellulosic advanced biofuels market is propelled by the ever-growing global demand for sustainable and renewable fuel sources, which has prompted significant investments and initiatives in the biofuel industry. This heightened demand is a direct response to the increasing environmental concerns and the urgent need to reduce greenhouse gas emissions. Furthermore, the advancements in technology within the sector have enabled the efficient conversion of cellulosic feedstocks, such as agricultural residues, grasses, and wood, into advanced biofuels, fostering a more sustainable and eco-friendly energy landscape. The surge in research and development activities aimed at enhancing the efficiency and scalability of cellulosic biofuel production has been instrumental in driving the market forward. Technological innovations have led to the development of robust and cost-effective processes for the conversion of cellulosic materials into high-quality biofuels, thereby promoting the widespread adoption of these eco-friendly alternatives in various industries and applications. As the global focus on sustainability intensifies and the demand for renewable energy sources continues to rise, the global cellulosic advanced biofuels market is expected to witness sustained growth and play an increasingly significant role in the global energy transition.

Green Biologics Frequently Asked Questions (FAQ)

  • When was Green Biologics founded?

    Green Biologics was founded in 2003.

  • Where is Green Biologics's headquarters?

    Green Biologics's headquarters is located at 80F Park Drive, Milton Park, Oxon.

  • What is Green Biologics's latest funding round?

    Green Biologics's latest funding round is Debt.

  • How much did Green Biologics raise?

    Green Biologics raised a total of $112.7M.

  • Who are the investors of Green Biologics?

    Investors of Green Biologics include Swire Pacific, Sofinnova Partners, Tennenbaum Capital Partners, Oxford Capital Partners, Morningside Ventures and 6 more.

  • Who are Green Biologics's competitors?

    Competitors of Green Biologics include Minerva Biotechnologies, Geno, Bone Biologics, Agrivida, OPX Biotechnologies and 7 more.


Compare Green Biologics to Competitors

Agrivida Logo

Agrivida is an agricultural biotechnology company developing energy crops designed to produce chemicals, fuels, and bioproducts from non-food cellulosic biomass. The company's approach is designed to provide an integrated solution for delivering the lowest-cost sugars that are essential for industrial bioproducts. The basis of Agrivida's integrated solution is engineering the feedstock to contain cell wall-degrading enzymes, and other valuable traits, which are activated following harvest. Agrivida plans to commercialize its platform through alliances across the bioindustrial product supply chain.


ProtAffin is a pre-clinical biotechnology company developing protein-based products countering inflammation. Its biologics targets the heparin-like glycan structures that drive inflammatory processes.

OrgSyn Laboratory

OrgSyn Laboratory focuses on the development of new methodologies in organic synthesis within the academic research sector. Their main research involves creating organic molecules through innovative redox processes, including photocatalysis and electrocatalysis, and exploring the use of piezoelectric materials for electron transfer-induced processes. The laboratory primarily contributes to the field of chemical research and education. It is based in Chicago, Illinois.

Akron Biotechnology

Akron Biotechnology is a company focused on the manufacturing of ancillary materials for the cell and gene therapy industry. The company offers a range of products and services including cytokines, growth factors, blood-derived products, and custom media, as well as manufacturing services for plasmid DNA, proteins, nucleases, and transfection and transduction reagents. Akron Biotechnology primarily serves the cell and gene therapy industry. It was founded in 2006 and is based in Boca Raton, Florida.

Laureate Pharma

Laureate Pharma is a company focused on the healthcare and pharmaceutical industry. It provides a range of services including the synthesis of pharmaceutical substances, the creation of finished dosage forms, and the development and launch of pulmonary drugs. The company primarily sells to the healthcare sector, with a focus on pharmacies and other pharmaceutical companies. It is based in Princeton, New Jersey.

Athena Environmental Sciences

Athena Environmental Sciences is a biotechnology company focused on improving protein production and purification. The company offers a range of products including biotechnology instrumentation, reagents, expression systems, cell culture media, and protein refolding kits, all designed to enhance the expression, recovery, and purification of proteins. AthenaES primarily serves research, biopharmaceutical, and industrial sectors with their specialized biotools. It is based in Baltimore, Maryland.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.